Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
J J Badimon, … , L Badimon, V Fuster
J J Badimon, … , L Badimon, V Fuster
Published April 1, 1990
Citation Information: J Clin Invest. 1990;85(4):1234-1241. https://doi.org/10.1172/JCI114558.
View: Text | PDF
Research Article Article has an altmetric score of 12

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

  • Text
  • PDF
Abstract

The effects of homologous plasma HDL and VHDL fractions on established atherosclerotic lesions were studied in cholesterol-fed rabbits. Atherosclerosis was induced by feeding the animals a 0.5% cholesterol-rich diet for 60 d (group 1). Another group of animals were maintained on the same diet for 90 d (group 2). A third group was also fed the same diet for 90 d but received 50 mg HDL-VHDL protein per wk (isolated from normolipemic rabbit plasma) during the last 30 d (group 3). Aortic atherosclerotic involvement at the completion of the study was 34 +/- 4% in group 1, 38.8 +/- 5% in group 2, and 17.8 +/- 4% in group 3 (P less than 0.005). Aortic lipid deposition was also significantly reduced in group 3 compared with group 1 (studied at only 60 d) and group 2. This is the first in vivo, prospective evidence of the antiatherogenic effect of HDL-VHDL against preexisting atherosclerosis. Our results showed that HDL plasma fractions were able to induce regression of established aortic fatty streaks and lipid deposits. Our results suggest that it may be possible not only to inhibit progression but even to reduce established atherosclerotic lesions by HDL administration.

Authors

J J Badimon, L Badimon, V Fuster

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1974 Total
Citations: 1 3 2 9 12 15 13 21 23 21 18 45 15 19 30 30 26 29 21 21 11 20 17 20 18 18 20 13 18 15 21 19 15 9 7 2 1 618
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (618)

Title and authors Publication Year
HDL-replacement therapy: From traditional to emerging clinical applications
Sirtori CR, Cincotto G, Castiglione S, Pavanello C
Atherosclerosis Plus 2025
Effect of moderate-intensity statin on carotid intraplaque neovascularization of coronary artery disease: a retrospective cohort study
Han Y, Ren L, Fei X, Wang J, Chen T, Guo J, Wang Q
Quantitative imaging in medicine and surgery 2024
Neuroprotective aftermath of Monodora myristica and Glycyrrhiza glabra against cassava diet containing vacuum gas oil induced brain injury in Wistar rats
Okpoghono J, Ukperegbulem JK, Onyesom I
Toxicology Reports 2024
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution
Hong NE, Chaplin A, Di L, Ravodina A, Bevan GH, Gao H, Asase C, Gangwar RS, Cameron MJ, Mignery M, Cherepanova O, Finn AV, Nayak L, Pieper AA, Maiseyeu A
Cell reports 2024
HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS.
Cordero A, Muñoz-García N, Padró T, Vilahur G, Bertomeu-González V, Escribano D, Flores E, Zuazola P, Badimon L
International journal of molecular sciences 2023
Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk
Murakami K, Harada A, Toh R, Kubo T, Miwa K, Kim J, Kiriyama M, Iino T, Nishikawa Y, Uno SN, Akatsuchi K, Nagao M, Ishida T, Hirata KI
Scientific Reports 2023
Addressing dyslipidemic risk beyond LDL cholesterol
Alan Tall, David Thomas, Ainara Cabodevilla, Ira Goldberg
Journal of Clinical Investigation 2022
Atherosclerosis: Methods and Protocols
D Ramji
2022
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Kalayci A, Gibson CM, Ridker PM, Wright SD, Kingwell BA, Korjian S, Chi G, Lee JJ, Tricoci P, Kazmi SH, Fitzgerald C, Shaunik A, Berman G, Duffy D, Libby P
Current Atherosclerosis Reports 2022
Fat-1 expression alleviates atherosclerosis in transgenic rabbits.
Zhang C, Wang X, Sun S, Fu Y, Wu Y, Zhao S, Fan X, Liu E
Journal of Cellular and Molecular Medicine 2022
Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection.
Kadji Fassi JB, Boukeng Jatsa H, Membe Femoe U, Greigert V, Brunet J, Cannet C, Kenfack CM, Gipwe Feussom N, Tienga Nkondo E, Abou-Bacar A, Pfaff AW, Kamgang R, Kamtchouing P, Tchuem Tchuenté LA
PLoS neglected tropical diseases 2022
OXIDATIVE MODIFICATION OF HDL BY LIPID ALDEHYDES IMPACTS HDL FUNCTION
Fadaei R, Davies SS
Archives of Biochemistry and Biophysics 2022
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL
European Heart Journal 2022
Consumption of Barley Bread Rich in Beta-Glucan During an Overfeeding Improves the Serum Lipid Profile and Balances the Intestinal Microbiota in Wistar Rats.
Kaoutar B, Kawthar B, Omar K
Indian Journal of Microbiology 2022
Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages
Kluck GE, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL
Arteriosclerosis, thrombosis, and vascular biology 2022
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
L Schoch, L Badimon, G Vilahur
Biomedicines 2021
Is a High HDL-Cholesterol Level Always Beneficial?
B Franczyk, J Rysz, J Ławiński, M Rysz-Górzyńska, A Gluba-Brzózka
Biomedicines 2021
HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
BA Bartolo, SP Cartland, S Genner, PM Cholan, M Vellozzi, KA Rye, MM Kavurma, FC Sasso
Journal of Diabetes Research 2021
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
KT Lappegård, CA Kjellmo, A Hovland
Biomedicines 2021
HDL cholesterol: A potential mediator of the association between urinary cadmium concentration and cardiovascular disease risk
C Xu, Z Weng, L Zhang, J Xu, M Dahal, TB Basnet, A Gu
Ecotoxicology and Environmental Safety 2021
The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease
Y Jia, W Wen, Y Yang, M Huang, Y Ning, X Jiao, S Liu, Y Qin, M Zhang
Clinical Biochemistry 2021
Incidence and risk factors predicting deep venous thrombosis of lower extremity following spinal fractures
J Ma, P Du, J Qin, Y Zhou, N Liang, J Hu, Y Zhang, Y Zhu
Scientific Reports 2021
(r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?
KB Uribe, A Benito-Vicente, C Martin, F Blanco-Vaca, N Rotllan
Biomaterials Science 2021
Anti-Atherogenic Effect of 10% Supplementation of Anchovy (Engraulis encrasicolus) Waste Protein Hydrolysates in ApoE-Deficient Mice
JM Abbate, F Macrì, F Arfuso, C Iaria, F Capparucci, C Anfuso, A Ieni, L Cicero, G Briguglio, G Lanteri
Nutrients 2021
Comparative effects of ethanol leaf and stem bark extracts of Irvingia gabonensis (BUSH MANGO) on sodium arsenite-induced lipid profile perturbtions in wistar rats
EG Ewere, NP Okolie, ED Avan, PE Umoh
Clinical Phytoscience 2021
Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics
DP Schrijver, A Dreu, SR Hofstraat, E Kluza, R Zwolsman, J Deckers, T Anbergen, K Bruin, MM Trines, EG Nugraha, F Ummels, RJ Röring, TJ Beldman, AJ Teunissen, ZA Fayad, R Meel, WJ Mulder
2021
Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats
C KAHRAMAN, H YAMAN
2021
Macrophages in Atherosclerosis Regression
TJ Barrett
Arteriosclerosis, thrombosis, and vascular biology 2020
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
EE Morin, Y Guo, H He, W Yuan, WN Souery, MV Fawaz, YE Chen, A Schwendeman
Frontiers in pharmacology 2020
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris
2020
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris
2020
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris
2020
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris
2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
J Borén, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, MJ Daemen, LL Demer, RA Hegele, SJ Nicholls, BG Nordestgaard, GF Watts, E Bruckert, S Fazio, BA Ference, I Graham, JD Horton, U Landmesser, U Laufs, L Masana, G Pasterkamp, FJ Raal, KK Ray, H Schunkert, MR Taskinen, B van de Sluis, O Wiklund, L Tokgozoglu, AL Catapano, HN Ginsberg
European Heart Journal 2020
Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis
M Zamanian-Daryoush, V Gogonea, AJ DiDonato, JA Buffa, I Choucair, BS Levison, RA Hughes, AD Ellington, Y Huang, XS Li, JA DiDonato, SL Hazen
The Journal of biological chemistry 2020
Immunization with the Gly 1127 -Cys 1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies
O Bornachea, A Benitez-Amaro, A Vea, L Nasarre, D de Gonzalo-Calvo, JC Escola-Gil, L Cedo, A Iborra, L Martínez-Martínez, C Juarez, JA Camara, C Espinet, M Borrell-Pages, L Badimon, J Castell, V Llorente-Cortés
Theranostics 2020
Hyperlipidaemia and cardioprotection: Animal models for translational studies
I Andreadou, R Schulz, L Badimon, A Adameová, P Kleinbongard, S Lecour, PE Nikolaou, I FalcãoPires, G Vilahur, N Woudberg, G Heusch, P Ferdinandy
British Journal of Pharmacology 2020
Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
S Jebari-Benslaiman, KB Uribe, A Benito-Vicente, U Galicia-Garcia, A Larrea-Sebal, I Alloza, K Vandenbroeck, H Ostolaza, C Martín
Biomedicines 2020
Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial
S Lakshmanan, C Shekar, A Kinninger, S Dahal, A Onuegbu, AN Cai, S Hamal, D Birudaraju, L Cherukuri, F Flores, C Dailing, SK Roy, DL Bhatt, JR Nelson, MJ Budoff
Atherosclerosis 2020
Textbook of Sports and Exercise Cardiology
A Pressler, J Niebauer
2020
Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
M Niimi, Y Chen, H Yan, Y Wang, T Koike, J Fan
Applied Sciences 2020
ASSOCIATION OF IRISIN WITH THE OXIDANT-ANTI OXIDANT PARAMETERS IN TYPE 2 DIABETIC PATIENTS ACCORDING TO AGE IN THI-QAR PROVINCE/ IRAQ
SH Al-Badry, KG Al-Fartoosi
2020
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
D Wang, Y Yang, Y Lei, NT Tzvetkov, X Liu, AW Yeung, S Xu, AG Atanasov, Q Ma
Pharmacological reviews 2019
Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice
K Méndez-Lara, N Farré, D Santos, A Rivas-Urbina, J Metso, J Sánchez-Quesada, V Llorente-Cortes, T Errico, E Lerma, M Jauhiainen, J Martín-Campos, N Alonso, J Escolà-Gil, F Blanco-Vaca, J Julve
International journal of molecular sciences 2019
HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension
K Jonas, G Kopeć
International journal of molecular sciences 2019
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
CR Sirtori, M Ruscica, L Calabresi, G Chiesa, R Giovannoni, JJ Badimon
Annals of Medicine 2019
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis
S Shea, JH Stein, NW Jorgensen, RL McClelland, L Tascau, S Shrager, JW Heinecke, L Yvan-Charvet, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2019
The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
H Daida, T Dohi, Y Fukushima, H Ohmura, K Miyauchi
Journal of Atherosclerosis and Thrombosis 2019
HDL and ASCVD Risk Stratification – A Debate
P Barter, J Genest
Atherosclerosis 2019
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
P Fotakis, V Kothari, DG Thomas, M Westerterp, MM Molusky, E Altin, S Abramowicz, N Wang, Y He, JW Heinecke, KE Bornfeldt, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2019
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
A Hernández-Mijares, JF Ascaso, M Blasco, Á Brea, Á Díaz, T Mantilla, J Pedro-Botet, X Pintó, J Millán
Clínica e Investigación en Arteriosclerosis (English Edition) 2019
Fundamentals of Vascular Biology
M Geiger
2019
Mathematical Modelling and Simulation of Atherosclerosis Formation and Progress: A Review
NA Avgerinos, P Neofytou
Annals of Biomedical Engineering 2019
A Compendium of the Biological Effects of Apolipoprotein A-I Milano
C Parolini
The Journal of pharmacology and experimental therapeutics 2019
A Photo-Activatable Peptide Mimicking Functions of Apolipoprotein A-I
H Kawahara, N Miyashita, K Tachibana, Y Tsuda, K Morimoto, K Tsuji, A Shigenaga, A Otaka, T Ishida, K Okuhira
Biological & Pharmaceutical Bulletin 2019
Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression
K Rahman, EA Fisher
Frontiers in Cardiovascular Medicine 2018
Pharmacological Intervention to Modulate HDL: What Do We Target?
NJ Woudberg, S Pedretti, S Lecour, R Schulz, N Vuilleumier, RW James, MA Frias
Frontiers in pharmacology 2018
Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease
A Haghikia, U Landmesser
JACC: Basic to Translational Science 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
SJ Nicholls, J Andrews, JJ Kastelein, B Merkely, SE Nissen, KK Ray, GG Schwartz, SG Worthley, C Keyserling, JL Dasseux, L Griffith, SW Kim, A Janssan, GD Giovanni, AD Pisaniello, DJ Scherer, PJ Psaltis, J Butters
JAMA Cardiology 2018
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation
AR Tall
Atherosclerosis 2018
移植肾动脉狭窄的临床危险因素和保护因素
2018
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
SJ Nicholls, R Puri, CM Ballantyne, JW Jukema, JJ Kastelein, W Koenig, RS Wright, D Kallend, P Wijngaard, M Borgman, K Wolski, SE Nissen
JAMA Cardiology 2018
CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both
SJ Nicholls
Clinical Pharmacology & Therapeutics 2018
High-Density Lipoprotein Infusions
K Takata, BA Bartolo, SJ Nicholls
Cardiology Clinics 2018
Antioxidant capacity of omega-3-fatty acids and vitamin E against imidacloprid-induced hepatotoxicity in Japanese quails
H Emam, E Ahmed, M Abdel-Daim
Environmental Science and Pollution Research 2018
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
I Karalis, JW Jukema
Current Cardiology Reports 2018
Cholesterol - Good, Bad and the Heart
ML Nagpal
2018
Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage
VA Kudinov, TS Zakharova, TI Torkhovskaya, OM Ipatova, АI Archakov
Biomeditsinskaya Khimiya 2018
Lipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanism
SY Chen, N Li, TL Jin, L Gou, DX Hao, ZQ Tian, SL Zhang, L Zhang
Chinese Physics B 2018
Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use
VA Kudinov, TS Zakharova, TI Torkhovskaya, OM Ipatova, AI Archakov
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2018
High-Density Lipoprotein–Targeted Therapies—Not Dead Yet
A Garcia-Ropero, CG Santos-Gallego, JJ Badimon
JAMA Cardiology 2018
Translating Evidence of HDL and Plaque Regression
BA Bartolo, PJ Psaltis, CA Bursill, SJ Nicholls
Arteriosclerosis, thrombosis, and vascular biology 2018
Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos
A Hernández-Mijares, JF Ascaso, M Blasco, Á Brea, Á Díaz, T Mantilla, J Pedro-Botet, X Pintó, J Millán
Clínica e Investigación en Arteriosclerosis 2018
Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: A novel index for the prediction of HDL functionality
CM Shih, FY Lin, JS Yeh, YW Lin, SH Loh, NW Tsao, H Nakagami, R Morishita, T Sawamura, CY Li, CY Lin, CY Huang
Translational research : the journal of laboratory and clinical medicine 2018
Endovascular Interventions
JM Wiley, C Sanina, P Faries, ID Conde, GD Dangas, P Krishnan
2018
[A high level of high-density lipoprotein cholesterol is a protective factor against transplant renal artery stenosis]
Yan-Na Liu, Li-Xin Yu, Wen-Feng Deng, Kai-Qun Li, Ru-Min Liu, Gui-Rong Ye, Fang-Xiang Fu, Jiang-Tao Li, Yun Miao
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2018
Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism: Inflammation and HDL-C metabolism
F Iqbal, WS Baker, MI Khan, S Thukuntla, KH McKinney, N Abate, D Tuvdendorj
British Journal of Pharmacology 2017
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
HH Wang, G Garruti, M Liu, P Portincasa, DQ Wang
ANN HEPATOL 2017
HDL cholesterol: reappraisal of its clinical relevance
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs
Clinical Research in Cardiology 2017
Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function
CL Millar, Q Duclos, CN Blesso
Advances in nutrition (Bethesda, Md.) 2017
The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review
A Pizzini, L Lunger, E Demetz, R Hilbe, G Weiss, C Ebenbichler, I Tancevski
Nutrients 2017
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
J Martin-Ventura, R Rodrigues-Diez, D Martinez-Lopez, M Salaices, L Blanco-Colio, A Briones
International journal of molecular sciences 2017
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance
N Paulin, Y Döring, S Kooijman, X Blanchet, JR Viola, R Jong, M Mandl, J Hendrikse, M Schiener, P Hundelshausen, A Vogt, C Weber, K Bdeir, SM Hofmann, PC Rensen, M Drechsler, O Soehnlein
EBioMedicine 2017
Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
AD Chalmers, CA Bursill, MR Myerscough, AV Panfilov
PloS one 2017
High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
E Androulakis, E Zacharia, N Papageorgiou, E Lioudaki, D Bertsias, M Charakida, G Siasos, D Tousoulis
Current cardiology reviews 2017
Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo
F Maafi, B Li, C Gebhard, MR Brodeur, W Nachar, L Villeneuve, F Lesage, D Rhainds, E Rhéaume, JC Tardif
Atherosclerosis 2017
HDL cholesterol concentration or HDL function: which matters?
PJ Barter, KA Rye
European Heart Journal 2017
Biofunctional polymer-lipid hybrid high density lipoprotein-mimicking nanoparticles loading anti-miR155 for combined antiatherogenic effects on macrophages
J Lu, Y Zhao, X Zhou, JH He, Y Yang, C Jiang, Z Qi, W Zhang, J Liu
Biomacromolecules 2017
Nanoplumbers: biomaterials to fight cardiovascular diseases
F Dormont, M Varna, P Couvreur
Materials Today 2017
Protective effects of Eruca sativa (rocket) on abamectin insecticide toxicity in male albino rats
NM Meligi, HF Hassan
Environmental Science and Pollution Research 2017
Type V hypertriglyceridemia in children, a therapeutic challenge in pediatrics: A case report and a review of the literature
CO Mărginean, LE Meliţ, M Dobreanu, MO Mărginean
Medicine 2017
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity
A Iqbal, A Dahl, A Lteif, S Kumar
Children 2017
Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: the JS high school study
JH Park, S Mun, DP Choi, JY Lee, HC Kim
BMC Pulmonary Medicine 2017
Effect of Ginkgo biloba Extract (EGb 761) on Serum Cholesterol Levels in Wild-type C57Bl/6 Mice
JS Hong, JW Kim, BI Yoon, KJ Rhee, CS Rha, BD Jung
Biomedical Science Letters 2017
High-Density Lipoprotein Nanobiologics for Precision Medicine
WJ Mulder, MM van Leent, M Lameijer, EA Fisher, ZA Fayad, C Pérez-Medina
Accounts of Chemical Research 2017
HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?
EP van der Vorst, K Theodorou, EA Biessen, MM Donners
Expert Review of Cardiovascular Therapy 2017
Petroleum ether extract of Njavara rice ( Oryza sativa ) bran upregulates the JAK2–STAT3-mediated anti-inflammatory profile in macrophages and aortic endothelial cells promoting regression of atherosclerosis
PK Chithra, A Jayalekshmy, A Helen
Biochemistry and Cell Biology 2017
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study
J Andrews, A Janssan, T Nguyen, AD Pisaniello, DJ Scherer, JJ Kastelein, B Merkely, SE Nissen, K Ray, GG Schwartz, SG Worthley, C Keyserling, JL Dasseux, J Butters, J Girardi, R Miller, SJ Nicholls
Cardiovascular diagnosis and therapy 2017
Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
BA di Bartolo, N Schwarz, J Andrews, SJ Nicholls
Archives of Medical Science : AMS 2017
miRNAs and High-Density Lipoprotein metabolism
Á Baldán, TQ de Vallim
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016
Micro-RNAs and High-Density Lipoprotein MetabolismHighlights
A Canfrán-Duque, CS Lin, L Goedeke, Y Suárez, C Fernández-Hernando
Arteriosclerosis, thrombosis, and vascular biology 2016
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury
AV Bocharov, T Wu, IN Baranova, AA Birukova, D Sviridov, TG Vishnyakova, AT Remaley, TL Eggerman, AP Patterson, KG Birukov
Journal of immunology (Baltimore, Md. : 1950) 2016
HDL—A molecule with a multi-faceted role in coronary artery disease
S Arora, SK Patra, R Saini
Clinica Chimica Acta 2016
Klinische Bedeutung des HDL-Cholesterins
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs
Herz 2016
New Era of Lipid-Lowering Drugs
PJ Barter, KA Rye
Pharmacological reviews 2016
Plaque stabilizing effects of apolipoprotein A-IV
FR Geronimo, PJ Barter, KA Rye, AK Heather, KD Shearston, KJ Rodgers
Atherosclerosis 2016
Animal models of myocardial infarction: Mainstay in clinical translation
M Kumar, ER Kasala, LN Bodduluru, V Dahiya, D Sharma, V Kumar, M Lahkar
Regulatory Toxicology and Pharmacology 2016
Long-term activation of the innate immune system in atherosclerosis
A Christ, S Bekkering, E Latz, NP Riksen
Seminars in Immunology 2016
Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio
S Kaul, H Xu, M Zabalawi, E Maruko, BE Fulp, T Bluemn, KL BrzozaLewis, M Gerelus, R Weerasekera, R Kallinger, R James, YS Zhang, MJ Thomas, MG SorciThomas
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications
JE Feig, JL Feig, GD Dangas
Coronary Artery Disease 2016
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?
B Enkhmaa, E Anuurad, L Berglund
Translational Research 2016
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia
J Cubedo, T Padró, R Alonso, P Mata, L Badimon
Journal of lipid research 2016
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction
CM Gibson, S Korjian, P Tricoci, Y Daaboul, JH Alexander, PG Steg, AM Lincoff, JJ Kastelein, R Mehran, D D'Andrea, B Merkely, M Zarebinski, TO Ophius, RA Harrington
American Heart Journal 2016
New Therapeutic Approaches to the Treatment of Dyslipidemia
DJ Rader
Cell Metabolism 2016
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
C Pérez-Medina, T Binderup, ME Lobatto, J Tang, C Calcagno, L Giesen, CH Wessel, J Witjes, S Ishino, S Baxter, Y Zhao, S Ramachandran, M Eldib, BL Sánchez-Gaytán, PM Robson, J Bini, JF Granada, KM Fish, ES Stroes, R Duivenvoorden, S Tsimikas, JS Lewis, T Reiner, V Fuster, A Kjær, EA Fisher, ZA Fayad, WJ Mulder
JACC: Cardiovascular Imaging 2016
HDL mimetic CER-001 targets atherosclerotic plaques in patients
KH Zheng, FM van der Valk, LP Smits, M Sandberg, JL Dasseux, R Baron, R Barbaras, C Keyserling, BF Coolen, AJ Nederveen, HJ Verberne, TE Nell, DJ Vugts, R Duivenvoorden, ZA Fayad, WJ Mulder, GA van Dongen, ES Stroes
Atherosclerosis 2016
Using Mendelian Randomization Studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine
W Zhao, JJ Lee, A Rasheed, D Saleheen
Current Genetic Medicine Reports 2016
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East
NA Sayed, KA Waili, F Alawadi, S Al-Ghamdi, WA Mahmeed, F Al-Nouri, MA Rukhaimi, K Al-Rasadi, Z Awan, M Farghaly, M Hassanein, H Sabbour, M Zubaid, P Barter
International Journal of Cardiology 2016
Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of AtherosclerosisHighlights
BK Wacker, N Dronadula, J Zhang, DA Dichek
Arteriosclerosis, thrombosis, and vascular biology 2016
Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond
BA di Bartolo, DJ Scherer, SJ Nicholls
Archives of Medical Science : AMS 2016
HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation
C Tardy, M Goffinet, N Boubekeur, G Cholez, R Ackermann, G Sy, C Keyserling, N Lalwani, JF Paolini, JL Dasseux, R Barbaras, R Baron, A Cignarella
PloS one 2015
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion
RE Temel, JM Brown
Trends in Pharmacological Sciences 2015
Cholesterol, inflammation and innate immunity
AR Tall, L Yvan-Charvet
Nature Reviews Immunology 2015
Novel methodologies for biomarker discovery in atherosclerosis
IE Hoefer, S Steffens, M Ala-Korpela, M Back, L Badimon, ML Bochaton-Piallat, CM Boulanger, G Caligiuri, S Dimmeler, J Egido, PC Evans, T Guzik, BR Kwak, U Landmesser, M Mayr, C Monaco, G Pasterkamp, J Tunon, C Weber
European Heart Journal 2015
Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine
J Fan, S Kitajima, T Watanabe, J Xu, J Zhang, E Liu, YE Chen
Pharmacology & Therapeutics 2015
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
KY Chyu, PK Shah
Frontiers in pharmacology 2015
Targeting High-Density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?
PJ Barter, KA Rye
Clinical Therapeutics 2015
Egg Phospholipids and Cardiovascular Health
C Blesso
Nutrients 2015
Innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/ LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
S Kühnast, M Fiocco, JW van der Hoorn, HM Princen, JW Jukema
European Journal of Pharmacology 2015
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
D Saleheen, R Scott, S Javad, W Zhao, A Rodrigues, A Picataggi, D Lukmanova, ML Mucksavage, R Luben, J Billheimer, JJ Kastelein, SM Boekholdt, KT Khaw, N Wareham, DJ Rader
The Lancet Diabetes & Endocrinology 2015
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory: The Dual Nature of HDL
R Namiri-Kalantari, F Gao, A Chattopadhyay, AA Wheeler, KD Navab, R Farias-Eisner, ST Reddy
BioFactors 2015
A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients
J Cubedo, T Padro, M Garcia-Arguinzonis, G Vilahur, I Minambres, JM Pou, J Ybarra, L Badimon
Journal of lipid research 2015
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
A Schwendeman, DO Sviridov, W Yuan, Y Guo, EE Morin, Y Yuan, J Stonik, L Freeman, A Ossoli, S Thacker, S Killion, M Pryor, YE Chen, S Turner, AT Remaley
Journal of lipid research 2015
Non-clinical development of CER-001
R Barbaras
Frontiers in pharmacology 2015
Novel Anti-Inflammatory Therapies for the Treatment of Atherosclerosis
R Khan, V Spagnoli, JC Tardif, PL L’Allier
Atherosclerosis 2015
Glycated apolipoprotein B—A surrogate marker of subclinical atherosclerosis
K Dev, SB Sharma, S Garg, A Aggarwal, SV Madhu
Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2015
HDL: quality or quantity?
CG Santos-Gallego
Atherosclerosis 2015
The role of a murine transplantation model of atherosclerosis regression in drug discovery
Jonathan E Feig, John S Quick, Edward A Fisher
Current opinion in investigational drugs (London, England : 2000) 2015
Site-specific Nitration of Apolipoprotein A-I at Tyrosine 166 Is Both Abundant within Human Atherosclerotic Plaque and Dysfunctional
JA DiDonato, K Aulak, Y Huang, M Wagner, G Gerstenecker, C Topbas, V Gogonea, AJ DiDonato, WH Tang, RA Mehl, PL Fox, EF Plow, JD Smith, EA Fisher, SL Hazen
The Journal of biological chemistry 2014
An abundant dysfunctional apolipoprotein A1 in human atheroma
Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li, Y Wu, J Buffa, T Kim, GS Gerstenecker, X Gu, CS Kadiyala, Z Wang, MK Culley, JE Hazen, AJ DiDonato, X Fu, SZ Berisha, D Peng, TT Nguyen, S Liang, CC Chuang, L Cho, EF Plow, PL Fox, V Gogonea, WH Tang, JS Parks, EA Fisher, JD Smith, SL Hazen
Nature Medicine 2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps
2014
Molecules That Mimic Apolipoprotein A-I: Potential Agents for Treating Atherosclerosis
LJ Leman, BE Maryanoff, MR Ghadiri
Journal of Medicinal Chemistry 2014
Beginning to Understand High-Density Lipoproteins
CG Santos-Gallego, JJ Badimon, RS Rosenson
Endocrinology and metabolism clinics of North America 2014
High-Density Lipoprotein and Atherosclerosis Regression: Evidence From Preclinical and Clinical Studies
JE Feig, B Hewing, JD Smith, SL Hazen, EA Fisher
Circulation research 2014
Regression of Atherosclerosis: Insights from Animal and Clinical Studies
JE Feig
Annals of Global Health 2014
Immunonutrition: Interactions of Diet, Genetics, and Inflammation
Z Li, D Heber
Immunonutrition: Interactions of Diet, Genetics, and Inflammation 2014
Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction
J Cubedo, T Padró, L Badimon
Translational Research 2014
HDL Cholesterol: All Hope Is Not Lost After the Torcetrapib Setback—Emerging Therapeutic Strategies on the Horizon
N Verma, VM Figueredo
American Journal of Therapeutics 2014
Trying to harness the potential of HDL: wishful thinking or sound strategy?
AM Fogelman
European Heart Journal 2014
HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: In vivo and in vitro studies: HDL3 Stimulates PON1 Antiatherogenic Properties
M Rosenblat, N Volkova, M Aviram
BioFactors 2014
Intake of cooked tomato sauce preserves coronary endothelial function and improves apolipoprotein A-I and apolipoprotein J protein profile in high-density lipoproteins
G Vilahur, J Cubedo, T Padró, L Casaní, G Mendieta, A González, L Badimon
Translational Research 2014
Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system
SP Deakin, V Ducret, S Bioletto, K Perron, RW James
Life Sciences 2014
Revising the high-density lipoprotein targeting strategies – Insights from human and preclinical studies
D Nesan, DS Ng
Critical Reviews in Clinical Laboratory Sciences 2014
HDL and cardiovascular disease
DJ Rader, GK Hovingh
The Lancet 2014
Examining controversies and new frontiers in lipid management
SJ Nicholls
Clinical Lipidology 2014
Cholesterol removal from plaques and elimination from the body: change in paradigm to reduce risk for heart disease
S Ghosh, J Bie, J Wang, Q Yuan, SS Ghosh
Clinical Lipidology 2014
High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need
Giovanni Cimmino, Giovanni Ciccarelli, Alberto Morello, Michele Ciccarelli, Paolo Golino
Translational medicine @ UniSa 2014
Atherosclerotic Plaque Imaging for Evaluation of HDL Targeting Therapy
Y Kataoka, SJ Nicholls
Journal of the Japanese Coronary Association 2014
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
Tenenbaum A, Klempfner R, Fisman EZ
Cardiovascular Diabetology 2014
Niacin, an old drug with a new twist
WL Song, GA FitzGerald
Journal of lipid research 2013
High density lipoprotein structure, function, and metabolism: a new Thematic Series
KA Rye
Journal of lipid research 2013
Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity
AJ Murphy, S Funt, D Gorman, AR Tall, N Wang
Circulation research 2013
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice
C Tardy, M Goffinet, N Boubekeur, R Ackermann, G Sy, A Bluteau, G Cholez, C Keyserling, N Lalwani, JF Paolini, JL Dasseux, R Barbaras, R Baron
Atherosclerosis 2013
High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
PJ Barter
Endocrinology and Metabolism 2013
Cardioprotective functions of HDLs
KA Rye, PJ Barter
Journal of lipid research 2013
A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines?
JA Salazar-González, S Rosales-Mendoza
Vaccine 2013
Recent progress in the development of apoA-I and apoE mimetic therapies
GM Anantharamaiah, DW Garber
Clinical Lipidology 2013
Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research
M Triolo, W Annema, RP Dullaart, UJ Tietge
Biomarkers in Medicine 2013
Animal Models for the Study of Human Disease
HA Lawson
Animal Models for the Study of Human Disease 2013
Validation of a novel homogeneous assay for of HDL3-C measurement
ME Ashmaig, S Gupta, JP McConnell, GR Warnick
Clinica Chimica Acta 2013
High-density lipoproteins: A consensus statement from the National Lipid Association
PP Toth, PJ Barter, RS Rosenson, WE Boden, MJ Chapman, M Cuchel, RB D'Agostino, MH Davidson, WS Davidson, JW Heinecke, RH Karas, A Kontush, RM Krauss, M Miller, DJ Rader
Journal of Clinical Lipidology 2013
Reconstituted HDL for the acute treatment of acute coronary syndrome:
BR Krause, AT Remaley
Current Opinion in Lipidology 2013
Modelos experimentales de aterosclerosis
CG Santos-Gallego, JJ Badimon, B Ibáñez
Revista Española de Cardiología Suplementos 2013
Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding
Kempen, O Fedorov, P Filippakopoulos, S Nicklisch, S Knapp, S Picaud
Lipid insights 2013
Emerging Role of Mast Cells and Macrophages in Cardiovascular and Metabolic Diseases
JM Xu, GP Shi
Endocrine reviews 2012
Macrophages, dendritic cells, and regression of atherosclerosis
JE Feig, JL Feig
Frontiers in physiology 2012
Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
C Ibuki, Y Seino, T Otsuka, N Kimata, T Inami, R Munakata, K Mizuno
Journal of clinical medicine research 2012
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
C Besler, TF Lüscher, U Landmesser
EMBO Molecular Medicine 2012
High-density lipoprotein function, dysfunction, and reverse cholesterol transport
EA Fisher, JE Feig, B Hewing, SL Hazen, JD Smith
Arteriosclerosis, thrombosis, and vascular biology 2012
HDL and cardiovascular risk: time to call the plumber?
B Hewing, KJ Moore, EA Fisher
Circulation research 2012
Evacetrapib
SJ Nicholls
Current Cardiology Reports 2012
The Rabbit as an Experimental Model
TH Burkholder, G Linton, RF Hoyt, R Young
The Laboratory Rabbit Guinea Pig Hamster and Other Rodents 2012
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
SJ Nicholls, A Gordon, J Johannson, CM Ballantyne, PJ Barter, HB Brewer, JJ Kastelein, NC Wong, MR Borgman, SE Nissen
Cardiovascular Drugs and Therapy 2012
Targeting HDL-cholesterol to reduce residual cardiovascular risk :
AO Iacob, RP Choudhury
Current Opinion in Lipidology 2012
High-density lipoprotein subclasses and their relationship to cardiovascular disease
HR Superko, L Pendyala, PT Williams, KM Momary, SB King, BC Garrett
Journal of Clinical Lipidology 2012
Intracoronary IVUS for Evaluation of Atherosclerosis Progression
K Uno, Y Kataoka, R Puri, SJ Nicholls
Current Cardiovascular Imaging Reports 2012
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance
F Borthwick, S Warnakula, R Mangat, RR Uwiera, JC Russell, SE Kelly, CY Lee, L Hryshko, JC Mamo, KA Rye, GD Lopaschuk, SD Proctor
Atherosclerosis 2012
Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins
S Chtourou, M Poulle
Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins 2012
Atherosclerosis: Treatment and Prevention
GP Shi, P Libby
Atherosclerosis: Treatment and Prevention 2012
HDL-C: Does it matter? An update on novel HDL-directed pharmaco-therapeutic strategies
R Gadi, A Amanullah, VM Figueredo
International Journal of Cardiology 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
PJ Barter, KA Rye
Journal of lipid research 2012
Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a Chinese population
C Weng, H Yuan, X Tang, Z Huang, K Yang, W Chen, P Yang, Z Chen, F Chen
International journal of medical sciences 2012
A Leukocyte-Mimetic Magnetic Resonance Imaging Contrast Agent Homes Rapidly to Activated Endothelium and Tracks With Atherosclerotic Lesion Macrophage Content
MA McAteer, K Mankia, N Ruparelia, A Jefferson, HB Nugent, LA Stork, KM Channon, JE Schneider, RP Choudhury
Arteriosclerosis, thrombosis, and vascular biology 2012
Antagonism of miR-33 in Mice Promotes Reverse Cholesterol Transport and Regression of Atherosclerosis
Katey J. Rayner, Frederick J. Sheedy, Christine C. Esau, Farah N. Hussain, Ryan E. Temel, Saj Parathath, Janine M. van Gils, Alistair J. Rayner, Aaron N. Chang, Yajaira Suarez, Carlos Fernandez-Hernando, Edward A. Fisher, Kathryn J. Moore
Journal of Clinical Investigation 2011
Novel HDL-directed pharmacotherapeutic strategies
EM Degoma, DJ Rader
Nature reviews. Cardiology 2011
Experimental Models for the Investigation of High-Density Lipoprotein–Mediated Cholesterol Efflux
CG Santos-Gallego, C Giannarelli, JJ Badimón
Current Atherosclerosis Reports 2011
MicroRNA Modulation of Cholesterol Homeostasis
C Fernández-Hernando, KJ Moore, WC Sessa
Arteriosclerosis, thrombosis, and vascular biology 2011
A Systems Genetic Analysis of High Density Lipoprotein Metabolism and Network Preservation across Mouse Models
P Langfelder, LW Castellani, Z Zhou, E Paul, R Davis, EE Schadt, AJ Lusis, S Horvath, M Mehrabian
Biochimica et Biophysica Acta 2011
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
JE Feig, JX Rong, R Shamir, M Sanson, Y Vengrenyuk, J Liu, K Rayner, K Moore, M Garabedian, EA Fisher
Proceedings of the National Academy of Sciences 2011
The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice
I Zanotti, C Maugeais, M Pedrelli, M Gomaraschi, P Salgam, L Calabresi, F Bernini, H Kempen
British Journal of Pharmacology 2011
Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies
EV Craeyveld, SC Gordts, E Nefyodova, F Jacobs, BD Geest
Journal of Molecular Medicine 2011
Apo A-I Modulating Therapies
SJ Nicholls
Current Cardiology Reports 2011
Emerging therapeutic strategies to enhance HDL function
S Redondo, J Martínez-González, C Urraca, T Tejerina
Lipids in Health and Disease 2011
Effects of niacin on atherosclerosis and vascular function
N Ruparelia, JE Digby, RP Choudhury
Current Opinion in Cardiology 2011
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
ME Lobatto, V Fuster, ZA Fayad, WJ Mulder
Nature Reviews Drug Discovery 2011
The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
CG Santos-Gallego, F Torres, JJ Badimón
Clinical Lipidology 2011
Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds
CL Nykiforuk, Y Shen, EW Murray, JG Boothe, D Busseuil, E Rhéaume, JC Tardif, A Reid, MM Moloney
Plant Biotechnology Journal 2011
ETC-216 for coronary artery disease
SJ Nicholls, K Uno, Y Kataoka, SE Nissen
Expert Opinion on Biological Therapy 2011
Manufacturing and shelf stability of reconstituted high-density lipoprotein for infusion therapy
JS Kim, Y Kang, KH Son, SM Choi, KY Kim
Biotechnology and Bioprocess Engineering 2011
Adeno-associated Virus Serotype 8 ApoA-I Gene Transfer Reduces Progression of Atherosclerosis in ApoE-KO Mice: Comparison of Intramuscular and Intravenous Administration
G Cimmino, C Giannarelli, W Chen, M Alique, CG Santos-Gallego, V Fuster, RJ Hajjar, CE Walsh, JJ Badimon
Journal of Cardiovascular Pharmacology 2011
Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins
S Imaizumi, M Navab, C Morgantini, C Charles-Schoeman, F Su, F Gao, M Kwon, E Ganapathy, D Meriwether, R Farias-Eisner, AM Fogelman, ST Reddy
Circulation Journal 2011
Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits
MR Ozaki, EA de Almeida
Experimental and Toxicologic Pathology 2011
HDL-C: Role as a risk modifier
P Barter
Atherosclerosis Supplements 2011
Growth Hormone
VS Herman-Bonert, S Melmed
The Pituitary 2011
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression
AA Francis, GN Pierce
Experimental & Clinical Cardiology 2011
Preventive Cardiology: Companion to Braunwald's Heart Disease
PN Hopkins
Preventive Cardiology: Companion to Braunwald's Heart Disease 2011
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)
B Ibanez, C Giannarelli, G Cimmino, CG Santos-Gallego, M Alique, A Pinero, G Vilahur, V Fuster, L Badimon, JJ Badimon
Atherosclerosis 2011
Case Studies for Complementary Therapists
K Galvin, M Bishop
Case Studies for Complementary Therapists 2011
The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations
L Tian, M Fu
Journal of Endocrinological Investigation 2011
Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia
R Li, H Chao, KW Ko, S Cormier, C Dieker, EA Nour, S Wang, L Chan, K Oka
Journal of genetic syndrome & gene therapy 2011
Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins
S Imaizumi, M Navab, C Morgantini, C Charles-Schoeman, F Su, F Gao, M Kwon, E Ganapathy, D Meriwether, R Farias-Eisner, AM Fogelman, ST Reddy
Circulation Journal 2011
Atherosclerosis and Thrombosis: Insights from Large Animal Models
G Vilahur, T Padro, L Badimon
Journal of Biomedicine and Biotechnology 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Watts GF
European Heart Journal 2011
Future Therapeutic Directions in Reverse Cholesterol Transport
AV Khera, DJ Rader
Current Atherosclerosis Reports 2010
5A, an Apolipoprotein A-I Mimetic Peptide, Attenuates the Induction of House Dust Mite-Induced Asthma
X Yao, C Dai, K Fredriksson, PK Dagur, JP McCoy, X Qu, ZX Yu, KJ Keeran, GJ Zywicke, MJ Amar, AT Remaley, SJ Levine
Journal of immunology (Baltimore, Md. : 1950) 2010
Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease
PP Toth
Current Cardiology Reports 2010
Structure and Function of HDL Mimetics
M Navab, I Shechter, GM Anantharamaiah, ST Reddy, BJ Lenten, AM Fogelman
Arteriosclerosis, thrombosis, and vascular biology 2010
Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes
LR Brunham, JK Kruit, MR Hayden, CB Verchere
Current Diabetes Reports 2010
Cholesteryl ester transfer protein and its inhibition
O Weber, H Bischoff, C Schmeck, MF Böttcher
Cellular and Molecular Life Sciences 2010
Atherosclerosis regression and high-density lipoproteins
JM Lee, RP Choudhury
Expert Review of Cardiovascular Therapy 2010
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
EM Tsompanidi, MS Brinkmeier, EH Fotiadou, SM Giakoumi, KE Kypreos
Atherosclerosis 2010
Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
Z Chen, M Ichetovkin, M Kurtz, E Zycband, D Kawka, J Woods, X He, AS Plump, E Hailman
Lipids in Health and Disease 2010
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
JM Woo, Z Lin, M Navab, CV Dyck, Y Trejo-Lopez, KM Woo, H Li, LW Castellani, X Wang, N Iikuni, OJ Rullo, H Wu, AL Cava, AM Fogelman, AJ Lusis, BP Tsao
Arthritis Research & Therapy 2010
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model
WS Speidl, G Cimmino, B Ibanez, S Elmariah, R Hutter, MJ Garcia, V Fuster, ME Goldman, JJ Badimon
European Heart Journal 2010
Incremento de las HDL como arma terapéutica en la aterotrombosis
JJ Badimón, B Ibáñez
Revista Española de Cardiología 2010
Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?
JJ Badimón, CG Santos-Gallego, L Badimón
Revista Española de Cardiología 2010
Recombinant High-Density Lipoprotein Formulations
E Vucic, RS Rosenson
Current Atherosclerosis Reports 2010
Quantification of plaque neovascularization using contrast ultrasound: a histologic validation
D Moguillansky, X Leng, A Carson, L Lavery, A Schwartz, X Chen, FS Villanueva
European Heart Journal 2010
Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol
SJ Nicholls, K Uno, EM Tuzcu, SE Nissen
Current Atherosclerosis Reports 2010
A pathobiologic link between risk factors profile and morphological markers of carotid instability
A Mauriello, GM Sangiorgi, R Virmani, S Trimarchi, DR Holmes, FD Kolodgie, DG Piepgras, G Piperno, D Liotti, J Narula, P Righini, A Ippoliti, LG Spagnoli
Atherosclerosis 2010
Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis
A Lavoie, K Uno, O Bayturan, SJ Nicholls
Current Medical Research and Opinion 2010
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
R Waksman, R Torguson, KM Kent, AD Pichard, WO Suddath, LF Satler, BD Martin, TJ Perlman, JA Maltais, NJ Weissman, PJ Fitzgerald, HB Brewer
Journal of the American College of Cardiology 2010
Anti-inflammatory effects of apolipoprotein A-I in the rabbit
S Patel, BA di Bartolo, S Nakhla, AK Heather, TW Mitchell, W Jessup, DS Celermajer, PJ Barter, KA Rye
Atherosclerosis 2010
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
JC Tardif
Journal of Clinical Lipidology 2010
Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10 residue Class G* Apolipoprotein J peptide using solution NMR#
VK Mishra, MN Palgunachari, JS Hudson, R Shin, TD Keenum, NR Krishna, GM Anantharamaiah
Biochimica et Biophysica Acta 2010
Lipoproteínas de alta densidad y regresión de la arteriosclerosis: desde la teoría hasta la imagen
B Ibáñez
Clínica e Investigación en Arteriosclerosis 2010
Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis
JD Smith
Current opinion in investigational drugs (London, England : 2000) 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
Increasing High-Density Lipoprotein as a Therapeutic Target in Atherothrombotic Disease
JJ Badimón, B Ibáñez
Revista Española de Cardiología (English Edition) 2010
Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits
BH Cho, JR Park, MT Nakamura, BM Odintsov, MA Wallig, BH Chung
Experimental biology and medicine (Maywood, N.J.) 2010
Biochemical characterization of cholesteryl ester transfer protein inhibitors
M Ranalletta, KK Bierilo, Y Chen, D Milot, Q Chen, E Tung, C Houde, NH Elowe, M Garcia-Calvo, G Porter, S Eveland, B Frantz-Wattley, M Kavana, G Addona, P Sinclair, C Sparrow, EA O'Neill, KS Koblan, A Sitlani, B Hubbard, TS Fisher
Journal of lipid research 2010
Blood Rheology and the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio in Dyslipidaemic and Normolipidaemic Subjects
T Machida, H Sumino, M Fukushima, N Kotajima, H Amagai, M Murakami
J INT MED RES 2010
High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
EJ Schaefer
2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
T Li, JY Chiang
PPAR Research 2009
The 6th Annual World Congress on the Insulin Resistance Syndrome
ZT Bloomgarden
Diabetes care 2009
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
FM Sacks, LL Rudel, A Conner, H Akeefe, G Kostner, T Baki, G Rothblat, M la Llera-Moya, B Asztalos, T Perlman, C Zheng, P Alaupovic, JA Maltais, HB Brewer
Journal of lipid research 2009
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development
MN Duong, SJ Nicholls
Expert Opinion on Drug Discovery 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy
Paraoxonases in Inflammation, Infection, and Toxicology 2009
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
M Navab, GM Anantharamaiah, ST Reddy, BJ van Lenten, AM Fogelman
Diabetes 2009
The metabolism and anti-atherogenic properties of HDL
KA Rye, CA Bursill, G Lambert, F Tabet, PJ Barter
Journal of lipid research 2009
The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease
P Meyer, A Nigam, M Marcil, JC Tardif
Current Atherosclerosis Reports 2009
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries
SJ Nicholls
Current Opinion in Lipidology 2009
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review
DR Chirovsky, V Fedirko, Y Cui, V Sazonov, P Barter
European Journal of Cardiovascular Prevention & Rehabilitation 2009
Antilipogenic effect of green tea extract in C57BL/6J-Lepob/obmice
HJ Kim, SM Jeon, MK Lee, UJ Jung, SK Shin, MS Choi
Phytotherapy Research 2009
Novel Therapies for Increasing Serum Levels of HDL
PP Toth
Endocrinology & Metabolism Clinics of North America 2009
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
EV Craeyveld, J Lievens, F Jacobs, Y Feng, J Snoeys, BD Geest
Gene Therapy 2009
Promoting Mechanisms of Vascular Health
PR Moreno, J Sanz, V Fuster
Journal of the American College of Cardiology 2009
Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels
DJ Hausenloy, DM Yellon
Current Opinion in Cardiology 2009
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
JM Lee, MD Robson, LM Yu, CC Shirodaria, C Cunnington, I Kylintireas, JE Digby, T Bannister, A Handa, F Wiesmann, PN Durrington, KM Channon, S Neubauer, RP Choudhury
Journal of the American College of Cardiology 2009
Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?
G Fabbri, AP Maggioni
Advances in Therapy 2009
High-Density Lipoprotein and Progression Rate of Atherosclerosis in Intravascular Ultrasound Trials
SJ Nicholls
The American Journal of Cardiology 2009
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
FM Sacks, LL Rudel, A Conner, H Akeefe, G Kostner, T Baki, G Rothblat, M la Llera-Moya, B Asztalos, T Perlman, C Zheng, P Alaupovic, JA Maltais, HB Brewer
Journal of lipid research 2009
Contemporary Interventional Ultrasonography in Urology
O Ukimura, IS Gill
2009
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications
AT Remaley, M Amar, D Sviridov
Expert Review of Cardiovascular Therapy 2008
Atherosclerosis regression
JM Lee, AC Lindsay, I Kylintireas, RP Choudhury
Current Treatment Options in Cardiovascular Medicine 2008
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)
G Cimmino, B Ibanez, G Vilahur, WS Speidl, V Fuster, L Badimon, JJ Badimon
Journal of Cellular and Molecular Medicine 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LT Bloedon, R Dunbar, D Duffy, P Pinell-Salles, R Norris, BJ DeGroot, R Movva, M Navab, AM Fogelman, DJ Rader
Journal of lipid research 2008
HDL Metabolism and CETP Inhibition
RS Barkowski, WH Frishman
Cardiology in Review 2008
Acute effects of high-density lipoproteins: biochemical basis and clinical findings
G Chiesa, C Parolini, CR Sirtori
Current Opinion in Cardiology 2008
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
NK Kapur, D Ashen, RS Blumenthal
Vascular Health and Risk Management 2008
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides
BJ van Lenten, M Navab, GM Anantharamaiah, GM Buga, ST Reddy, AM Fogelman
Current opinion in investigational drugs (London, England : 2000) 2008
Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides
R Yu, B Yekta, L Vakili, N Gharavi, M Navab, D Marelli, A Ardehali
Current Atherosclerosis Reports 2008
High-density lipoprotein/apolipoprotein A-I infusion therapy
JC Tardif, T Heinonen, S Noble
Current Atherosclerosis Reports 2008
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
LJ Rijzewijk, RW van der Meer, JW Smit, M Diamant, JJ Bax, S Hammer, JA Romijn, A Roos, HJ Lamb
Journal of the American College of Cardiology 2008
The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis
M Navab, GM Anantharamaiah, AM Fogelman
Trends in Cardiovascular Medicine 2008
Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia
M Vergeer, JJ Kastelein
Nature Clinical Practice Cardiovascular Medicine 2008
High-density lipoprotein and atheroma monitoring
SJ Nicholls, EM Tuzcu
Current Opinion in Cardiology 2008
Cholesteryl Ester Transfer Protein Inhibition for Coronary Heart Disease Prevention: Real Hope or Despair?
WH Frishman, RS Barkowski
The American Journal of Medicine 2008
Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease
CM Rasnake, PR Trumbo, TM Heinonen
Nutrition Reviews 2008
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial
HR Underhill, C Yuan, XQ Zhao, LW Kraiss, DL Parker, T Saam, B Chu, N Takaya, F Liu, NL Polissar, B Neradilek, JS Raichlen, VA Cain, JC Waterton, W Hamar, TS Hatsukami
American Heart Journal 2008
Synthetic HDL as a new treatment for atherosclerosis regression: Has the time come?
P Conca, G Franceschini
Nutrition Metabolism and Cardiovascular Diseases 2008
Comprehensive Lipid Management Versus Aggressive Low-Density Lipoprotein Lowering to Reduce Cardiovascular Risk
RH Knopp, P Paramsothy, B Atkinson, A Dowdy
The American Journal of Cardiology 2008
Diabetes y enfermedad cardiovascular
V Fuster, B Ibáñez
Revista Española de Cardiología Suplementos 2008
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis
B Ibanez, G Cimmino, J Bénézet-Mazuecos, CG Santos-Gallego, A Pinero, S Prat-González, WS Speidl, V Fuster, MJ García, J Sanz, JJ Badimon
Atherosclerosis 2008
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis
B Ibanez, G Vilahur, G Cimmino, WS Speidl, A Pinero, BG Choi, MU Zafar, CG Santos-Gallego, B Krause, L Badimon, V Fuster, JJ Badimon
Journal of the American College of Cardiology 2008
HDL-cholesterol: Is it really good?
CG Santos-Gallego, B Ibanez, JJ Badimon
Biochemical Pharmacology 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LA Bloedon, R Dunbar, D Duffy, P Pinell-Salles, R Norris, BJ DeGroot, R Movva, M Navab, AM Fogelman, DJ Rader
Journal of lipid research 2008
The metabolism and anti-atherogenic properties of HDL
KA Rye, CA Bursill, G Lambert, F Tabet, PJ Barter
Journal of lipid research 2008
Differences in DBA/1J and DBA/2J reveal lipid QTL genes
IM Stylianou, SR Langley, K Walsh, Y Chen, C Revenu, B Paigen
Journal of lipid research 2008
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice
T Juan, MM Véniant, J Helmering, P Babij, DM Baker, MA Damore, MB Bass, T Gyuris, M Chhoa, CM Li, C Ebeling, J Amato, GA Carlson, DJ Lloyd
Journal of lipid research 2008
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto
2008
Comparison of coronary plaque composition among patients with acute coronary syndrome and stable coronary artery disease:
X LI, C HUANG, T WANG, S ZHUANG, H ZHOU, B TIAN
Chinese Medical Journal 2008
Modifying the anti-inflammatory effects of high-density lipoprotein
BJ Ansell, GC Fonarow, M Navab, AM Fogelman
Current Atherosclerosis Reports 2007
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease
HB Brewer
Current Cardiology Reports 2007
Emerging HDL-based therapies for atherothrombotic vascular disease
PK Shah
Current Treatment Options in Cardiovascular Medicine 2007
Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides
M Gomaraschi, L Calabresi, G Rossoni, S Iametti, G Franceschini, JA Stonik, AT Remaley
The Journal of pharmacology and experimental therapeutics 2007
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
Barter PJ, Puranik R, Rye KA
Current Cardiology Reports 2007
FULL TEXT Chapter 1: Introduction
&NA;
European Journal of Cardiovascular Prevention & Rehabilitation 2007
Molecular Mechanisms Responsible for the Anti-Inflammatory and Protective Effect of High-Density Lipoprotein on the Endothelium
GD Norata, AL Catapano
High Blood Pressure & Cardiovascular Prevention 2007
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease
PJ Barter, R Puranik, KA Rye
Current Cardiology Reports 2007
Exploring the natural history of atherosclerosis with intravascular ultrasound
SJ Nicholls, J Andrews, KW Moon
Expert Review of Cardiovascular Therapy 2007
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
D Liao, X Yang, H Wang
Clinical Chemistry and Laboratory Medicine 2007
Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
SJ Nicholls, EM Tuzcu, SE Nissen
Current Atherosclerosis Reports 2007
Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
PP Toth
Current Atherosclerosis Reports 2007
Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: In vivo demonstration by high-resolution MRI
R Corti, J Osende, R Hutter, JF Viles-Gonzalez, U Zafar, C Valdivieso, G Mizsei, JT Fallon, V Fuster, JJ Badimon
Atherosclerosis 2007
Vascular inflammation
V Fuster, J Sanz
Journal of the American Society of Hypertension 2007
New targets of high-density lipoprotein therapy
SJ Nicholls, SE Nissen
Current Opinion in Lipidology 2007
Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound
SR Kalidindi, EM Tuzcu, SJ Nicholls
International Journal of Clinical Practice 2007
Molecular Mechanisms Responsible for the Anti-Inflammatory and Protective Effect of High-Density Lipoprotein on the Endothelium:
GD Norata, AL Catapano
High Blood Pressure & Cardiovascular Prevention 2007
New targets of high-density lipoprotein therapy:
SJ Nicholls, SE Nissen
Current Opinion in Lipidology 2007
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
GM Anantharamaiah, VK Mishra, DW Garber, G Datta, SP Handattu, MN Palgunachari, M Chaddha, M Navab, ST Reddy, JP Segrest, AM Fogelman
Journal of lipid research 2007
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
LA Morehouse, ED Sugarman, PA Bourassa, TM Sand, F Zimetti, F Gao, GH Rothblat, AJ Milici
Journal of lipid research 2007
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding
2007
Aggressive Very Low-Density Lipoprotein (VLDL) and LDL Lowering by Gene Transfer of the VLDL Receptor Combined with a Low-Fat Diet Regimen Induces Regression and Reduces Macrophage Content in Advanced Atherosclerotic Lesions in LDL Receptor-Deficient Mice
ED MacDougall, F Kramer, P Polinsky, S Barnhart, B Askari, F Johansson, R Varon, ME Rosenfeld, K Oka, L Chan, SM Schwartz, KE Bornfeldt
The American Journal of Pathology 2006
The rationale for using apoA-I as a clinical marker of cardiovascular risk
PJ Barter, KA Rye
Journal of Internal Medicine 2006
HDL and endothelial function: from molecular mechanisms to clinical observations
GD Norata, S Raselli, AL Catapano
Future Lipidology 2006
Protection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions
I Sudano, LE Spieker, F Hermann, A Flammer, R Corti, G Noll, TF L??scher
Journal of Cardiovascular Pharmacology 2006
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases
L Calabresi, CR Sirtori, R Paoletti, G Franceschini
Current Atherosclerosis Reports 2006
High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells
A Cucina, MP Scavo, L Muzzioli, P Coluccia, S Ceccarini, A Fuso, A Cavallaro
Atherosclerosis 2006
Estrogen regulation of the scavenger receptor class B gene: Anti-atherogenic or steroidogenic, is there a priority?
D Lopez, MP McLean
Molecular and Cellular Endocrinology 2006
High-density lipoproteins: an emerging target in the prevention of cardiovascular disease
BA Cutri, NJ Hime, SJ Nicholls
Cell Research 2006
High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease
M Gomaraschi, L Calabresi, G Franceschini
Expert Opinion on Therapeutic Targets 2006
HDL inflammation and atherosclerosis: current and future perspectives
T Sampietro, F Bigazzi, M Puntoni, A Bionda
Future Cardiology 2006
HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigm
PK Shah
Future Lipidology 2006
Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
JM Lee, RP Choudhury
Heart (British Cardiac Society) 2006
Evaluación de la progresión y la regresión de la aterosclerosis coronaria mediante ecografía intravascular. ¿Un nuevo cambio de paradigma?
SJ Nicholls, I Sipahi, EM Tuzcu
Revista Española de Cardiología 2006
Therapeutic use of the high-density lipoprotein protein and peptides
M Marchesi, CR Sirtori
Expert Opinion on Investigational Drugs 2006
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention
M Navab, GM Anantharamaiah, ST Reddy, AM Fogelman
Nature Clinical Practice Cardiovascular Medicine 2006
Application of intravascular ultrasound in anti-atherosclerotic drug development
SJ Nicholls, I Sipahi, P Schoenhagen, T Crowe, EM Tuzcu, SE Nissen
Nature Reviews Drug Discovery 2006
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins
PJ Barter, KA Rye
Current Opinion in Lipidology 2006
Potential clinical utility of high-density lipoprotein-mimetic peptides
M Navab, GM Anantharamaiah, ST Reddy, BJ van Lenten, G Datta, D Garber, AM Fogelman
Current Opinion in Lipidology 2006
HDL: The ‘new’ target of cardiovascular medicine
T Sampietro, F Bigazzi, BD Pino, M Puntoni, A Bionda
International Journal of Cardiology 2006
Assessment of Progression and Regression of Coronary Atherosclerosis by Intravascular Ultrasound. A New Paradigm Shift?
SJ Nicholls, I Sipahi, EM Tuzcu
Revista Española de Cardiología (English Edition) 2006
Complex Genetic Architecture Revealed by Analysis of High-Density Lipoprotein Cholesterol in Chromosome Substitution Strains and F 2 Crosses
IM Stylianou, SW Tsaih, K DiPetrillo, N Ishimori, R Li, B Paigen, G Churchill
Genetics 2006
High-density lipoprotein function recent advances
BJ Ansell, KE Watson, AM Fogelman, M Navab, GC Fonarow
Journal of the American College of Cardiology 2005
Nonpharmacologic Approaches for the Treatment of Hyperlipidemia
T Kermani, WH Frishman
Cardiology in Review 2005
Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: Comparison with probucol
SM Jeon, YB Park, OS Kwon, TL Huh, WH Lee, KM Do, T Park, MS Choi
Journal of Biochemical and Molecular Toxicology 2005
High-density lipoprotein cholesterol in the cardiovascular equation: Does the “good” still count?
AA Alsheikh-Ali, JT Kuvin, RH Karas
Atherosclerosis 2005
Atherothrombosis and High-Risk Plaque
V Fuster, PR Moreno, ZA Fayad, R Corti, JJ Badimon
Journal of the American College of Cardiology 2005
High-density lipoproteins as therapeutic targets
SJ Nicholls, KA Rye, PJ Barter
Current Opinion in Lipidology 2005
BHUx: A Patent Polyherbal Formulation to Prevent Atherosclerosis
YB Tripathi, BK Singh, RS Pandey, M Kumar
Evidence-based complementary and alternative medicine : eCAM 2005
Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence
JR Nofer, M Walter, G Assmann
Expert Review of Cardiovascular Therapy 2005
Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
AS Wierzbicki
Current Medical Research and Opinion 2005
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging
R Corti, V Fuster, ZA Fayad, SG Worthley, G Helft, WF Chaplin, J Muntwyler, JF Viles-Gonzalez, J Weinberger, DA Smith, G Mizsei, JJ Badimon
Journal of the American College of Cardiology 2005
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium
GD Norata, AL Catapano
Vascular Health and Risk Management 2005
Anti-Inflammatory Properties of HDL
BJ Ansell, M Navab, KE Watson, GC Fonarow, AM Fogelman
Reviews in Endocrine and Metabolic Disorders 2004
Oral supplement of six selective amino acids arrest progression renal failure in uremic patients
H Yatzidis
International Urology and Nephrology 2004
Metabolic abnormalities: high-density lipoproteins
P Barter
Endocrinology & Metabolism Clinics of North America 2004
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
GK Hovingh, A Brownlie, RJ Bisoendial, MP Dube, JH Levels, W Petersen, RP Dullaart, ES Stroes, AH Zwinderman, E Groot, MR Hayden, JA Kuivenhoven, JJ Kastelein
Journal of the American College of Cardiology 2004
Genetic determinants of low high-density lipoprotein cholesterol
M Miller, M Zhan
Current Opinion in Cardiology 2004
Therapeutic approaches to raising plasma HDL-cholesterol levels
MM Thompson, SC Reed, GW Cockerill
Nature Clinical Practice Cardiovascular Medicine 2004
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease
GF Watts, JR Burnett
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004
Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex
S Kaul, B Coin, A Hedayiti, J Yano, B Cercek, KY Chyu, PK Shah
Journal of the American College of Cardiology 2004
New aspects in the pathogenesis of diabetic atherothrombosis
PR Moreno, V Fuster
Journal of the American College of Cardiology 2004
Conjugated linoleic acid isomer effects in atherosclerosis: Growth and regression of lesions
D Kritchevsky, SA Tepper, S Wright, SK Czarnecki, TA Wilson, RJ Nicolosi
Lipids 2004
Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL
J Martı́nez-González, I Escudero, L Badimon
Atherosclerosis 2004
Treating low HDL—From bench to bedside
DS Ng
Clinical Biochemistry 2004
Treatment of Vulnerable Plaques : Current and Future Strategies
D Brieger, SB Freedman, L Kritharides, H Lowe
High-Risk Atherosclerotic Plaques Mechanisms Imaging Models and Therapy 2004
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat
Revista Española de Cardiología (English Edition) 2004
Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat
Revista Española de Cardiología 2004
Importancia del colesterol ligado a lipoproteínas de alta densidad (cHDL) en la prevención del riesgo cardiovascular. Recomendaciones del Foro HDL
A J.F., FC A., GS P., HM A., MR A., M J., P L.F., J Pedro-Botet, PJ F., P G., X Pintó, I Plaza, J Rubiés-Prat
Clínica e Investigación en Arteriosclerosis 2004
Atherogenesis and vascular calcification in mice expressing the human LPA gene
PA Teivainen, KA Eliassen, K Berg, K Torsdalen, A Svindland
Pathophysiology 2004
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
M Navab, GM Ananthramaiah, ST Reddy, BJ van Lenten, BJ Ansell, GC Fonarow, K Vahabzadeh, S Hama, G Hough, N Kamranpour, JA Berliner, AJ Lusis, AM Fogelman
Journal of lipid research 2004
Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1
JF Ascaso, A Fernndez-Cruz, PG Santos, AH Mijares, AM Rojas, J Milln, LF Pallardo, J Pedro-Botet, F Prez-Jimnez, G Pa, X Pint, I Plaza, J Rubis-Prat
American Journal Cardiovascular Drugs 2004
Comparative effects of lipid-lowering therapies
MH Davidson, PP Toth
Progress in Cardiovascular Diseases 2004
Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol:
ML Kashyap, S Tavintharan, VS Kamanna
American Journal Cardiovascular Drugs 2003
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
GD Backer, E Ambrosioni, K Broch-Johnsen, C Brotons, R Cifkova, J Dallongeville, S Ebrahim, O Faergeman, I Graham, G Mancia, VM Cats, K Orth-Gom??r, J Perk, K Py??r??l??, JL Rodicio, S Sans, V Sansoy, U Sechtem, S Silber, T Thomsen, D Wood
European Journal of Cardiovascular Prevention and Rehabilitation 2003
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
SE Borggreve, R Vries, RP Dullaart
European Journal of Clinical Investigation 2003
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
P Barter, J Kastelein, A Nunn, R Hobbs
Atherosclerosis 2003
Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC
I Escudero, J Martinez-Gonzalez, R Alonso, P Mata, L Badimon
European Journal of Clinical Investigation 2003
Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol
M Zabalawi, S Bhat, T Loughlin, MJ Thomas, E Alexander, M Cline, B Bullock, M Willingham, MG Sorci-Thomas
The American Journal of Pathology 2003
Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes
JF Viles-Gonzalez, V Fuster, R Corti, JJ Badimon
Current Opinion in Cardiology 2003
Apolipoprotein A-IMilano: current perspectives
G Chiesa, CR Sirtori
Current Opinion in Lipidology 2003
new understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging
R Corti, V Fuster
The American Journal of Cardiology 2003
Effect of baseline levels on response of high-density lipoprotein cholesterol to hypolipidemic treatment
GD Kolovou, DC Daskalova, II Petropoulos, KK Anagnostopoulou, HI Bilianou, ND Pilatis, AN Pavlidis, DV Cokkinos
The American Journal of Cardiology 2003
Regulation of reverse cholesterol transport and clinical implications
DJ Rader
The American Journal of Cardiology 2003
Papel de los factores de riesgo en la trombogenicidad sanguínea y los síndromes coronarios agudos
A Sambola, V Fuster, JJ Badimon
Revista Española de Cardiología 2003
Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation
S Rosas, P Szapary, DJ Rader
Cardiology Clinics 2003
Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions
Yoshikazu Ishimoto, Katsutoshi Yamada, Shigenori Yamamoto, Takashi Ono, Mitsuru Notoya, Kohji Hanasaki
Biochimica et Biophysica Acta 2003
Phosphatidylinositol promotes cholesterol transport and excretion
JW Burgess, J Boucher, TA Neville, P Rouillard, C Stamler, S Zachariah, DL Sparks
Journal of lipid research 2003
Infections and the Cardiovascular System: New Perspectives
IW Fong
2003
High-Density Lipoproteins as an Emerging Therapeutic Target for Atherosclerosis
DJ Rader
Journal of the American Medical Association 2003
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Y Hata, H Mabuchi, Y Saito, H Itakura, G Egusa, H Ito, T Teramoto, M Tsushima, N Tada, S Oikawa, N Yamada, S Yamashita, N Sakuma, J Sasaki
Journal of Atherosclerosis and Thrombosis 2002
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann, A Eckardstein
Atherosclerosis 2002
Beyond LDL-C – The Importance of Raising HDL-C
AS Wierzbicki, DP Mikhailidis
Current Medical Research and Opinion 2002
Lack of inhibitory effect of HDL on TNFα-induced adhesion molecule expression in human aortic endothelial cells
WJ Zhang, R Stocker, MR McCall, TM Forte, B Frei
Atherosclerosis 2002
Anti-Atherosclerotic Effect of β-Blocker with Nitric Oxide–Releasing Action on the Severe Atherosclerosis
NK Thakur, T Hayashi, D Sumi, H Kano, H Matsui-Hirai, T Tsunekawa, A Iguchi
Journal of Cardiovascular Pharmacology 2002
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice
M Kawashiri, YZ Zhang, E Puré, DJ Rader
Atherosclerosis 2002
Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E
YX Wang, B Martin-McNulty, LY Huw, V Cunha, J Post, J Hinchman, R Vergona, ME Sullivan, W Dole, K Kauser
Atherosclerosis 2002
Biologic aspects of vulnerable plaque
R Corti, JJ Badimon
Current Opinion in Cardiology 2002
The Mikamo Lecture 2002
V Fuster, R Corti, JJ Badimon
Circulation Journal 2002
High-density lipoproteins and atherosclerosis
DJ Rader
The American Journal of Cardiology 2002
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations
FM Sacks
The American Journal of Cardiology 2002
Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks
G Chiesa, E Monteggia, M Marchesi, P Lorenzon, M Laucello, V Lorusso, CD Mario, E Karvouni, RS Newton, CL Bisgaier, G Franceschini, CR Sirtori
Circulation research 2002
High-density lipoprotein restores endothelial function in hypercholesterolemic men
LE Spieker, I Sudano, D Hürlimann, PG Lerch, MG Lang, C Binggeli, R Corti, F Ruschitzka, TF Lüscher, G Noll
Circulation 2002
Fisiopatología de la enfermedad aterotrombótica coronaria
JJ Badimon, B Badimon, V Fuster
Clínica e Investigación en Arteriosclerosis 2002
HDL therapy for the acute treatment of atherosclerosis
RS Newton, BR Krause
Atherosclerosis Supplements 2002
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL
B Angelin, P Parini, M Eriksson
Atherosclerosis Supplements 2002
HDL in risk prediction and its direct and indirect involvement in atherogenesis
P Durrington
Atherosclerosis Supplements 2002
Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
M Navab, GM Anantharamaiah, S Hama, DW Garber, M Chaddha, G Hough, R Lallone, AM Fogelman
Circulation 2002
Paraoxonase (PON1) in Health and Disease
LG Costa, CE Furlong
2002
Antioxidative Activity of Green Tea Polyphenol in Cholesterol-Fed Rats
T Yokozawa, T Nakagawa, K Kitani
Journal of Agricultural and Food Chemistry 2002
Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells
A Stannard
Atherosclerosis 2001
Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
PJ Barter, KA Rye
Current Opinion in Lipidology 2001
CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation
DL Feldman, WK Sawyer, MR Jeune, TC Mogelesky, JV Linden-Reed, MF Prescott
Atherosclerosis 2001
New Understanding of Atherosclerosis (Clinically and Experimentally) with Evolving MRI Technology in Vivo
R Corti, V Fuster, JJ Badimon, R Hutter, ZA Fayad
Annals of the New York Academy of Sciences 2001
Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport
RP Dullaart, A Tol
Diabetic Medicine 2001
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu
Heart Physiology and Pathophysiology 2001
High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock
GW Cockerill, MC McDonald, H Mota-Filipe, S Cuzzocrea, NE Miller, C Thiemermann
The FASEB Journal 2001
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
PP Toth
Disease-a-Month 2001
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis
DW Garber, G Datta, M Chaddha, MN Palgunachari, SY Hama, M Navab, AM Fogelman, JP Segrest, GM Anantharamaiah
Journal of lipid research 2001
Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E–deficient mouse in a novel transplantation model
ED Reis, J Li, ZA Fayad, JX Rong, D Hansoty, JG Aguinaldo, JT Fallon, EA Fisher
Journal of Vascular Surgery 2001
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
PK Shah, S Kaul, J Nilsson, B Cercek
Circulation 2001
Paraoxonase and Atherosclerosis
PN Durrington, B Mackness, MI Mackness
Arteriosclerosis, thrombosis, and vascular biology 2001
Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E-Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content
JX Rong, J Li, ED Reis, RP Choudhury, HM Dansky, VI Elmalem, JT Fallon, JL Breslow, EA Fisher
Circulation 2001
Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation
GW Cockerill, TY Huehns, A Weerasinghe, C Stocker, PG Lerch, NE Miller, DO Haskard
Circulation 2001
Does Therapeutic Intervention Achieve Slowing of Progression or Bona Fide Regression of Atherosclerotic Lesions?
Y Stein, O Stein
Arteriosclerosis, thrombosis, and vascular biology 2001
Inhibition of Cholesterol Efflux by 7-Ketocholesterol: Comparison between Cells, Plasma Membrane Vesicles, and Liposomes as Cholesterol Donors
K Gaus, RT Dean, L Kritharides, W Jessup
Biochemistry 2001
In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
CC Hedrick, LW Castellani, H Wong, AJ Lusis
Journal of lipid research 2001
Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux
PG Yancey, WG Jerome
Journal of lipid research 2001
Postprandial lipemia and coronary risk
W Patsch, H Esterbauer, B Föger, JR Patsch
Current Atherosclerosis Reports 2000
High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis
M Kawashiri, C Maugeais, DJ Rader
Current Atherosclerosis Reports 2000
The role of plaque rupture and thrombosis in coronary artery disease
AG Zaman, G Helft, SG Worthley, JJ Badimon
Atherosclerosis 2000
Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease
PK Shah
Expert Opinion on Investigational Drugs 2000
Gene therapy for lipid disorders
MK Ma, DJ Rader
Current controlled trials in cardiovascular medicine 2000
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
M Mackness, A Bouiller, N Hennuyer, B Mackness, M Hall, A Tailleux, P Duriez, B Delfly, P Durrington, JC Fruchart, N Duverger, JM Caillaud, G Castro
Biochemical and Biophysical Research Communications 2000
Prevention
JS Forrester
Current Opinion in Cardiology 2000
Formation of HDL-like complexes from apolipoprotein A-IM and DMPC
M Suurkuusk, SK Singh
International Journal of Pharmaceutics 2000
MANAGEMENT OF SELECTED LIPID ABNORMALITIES
DJ Rader, S Rosas
Medical Clinics of North America 2000
Role of plaque rupture in acute coronary syndromes
JS Forrester
The American Journal of Cardiology 2000
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport
KJ Williams, R Scalia, KD Mazany, WV Rodrigueza, AM Lefer
Arteriosclerosis, thrombosis, and vascular biology 2000
Influence of Conjugated Linoleic Acid (CLA) on Establishment and Progression of Atherosclerosis in Rabbits
D Kritchevsky, SA Tepper, S Wright, P Tso, SK Czarnecki
Journal of the American College of Nutrition 2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
M Navab, SY Hama, CJ Cooke, GM Anantharamaiah, M Chaddha, L Jin, G Subbanagounder, KF Faull, ST Reddy, NE Miller, AM Fogelman
Journal of lipid research 2000
Apolipoprotein A-I, Phospholipid Vesicles, and Cyclodextrins as Potential Anti-Atherosclerotic Drugs: Delivery, Pharmacokinetics, and Efficacy
CR Jessup
Drug Delivery 2000
Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review
C R Dass, W Jessup
The Journal of pharmacy and pharmacology 2000
Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice
C Desurmont, JM Caillaud, F Emmanuel, P Benoit, JC Fruchart, G Castro, D Branellec, JM Heard, N Duverger
Arteriosclerosis, thrombosis, and vascular biology 2000
Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally
BS Dhaliwal, UP Steinbrecher
Journal of lipid research 2000
Risk Reduction
V Fuster, AM Gotto
Circulation 2000
Gene therapy for dyslipidemia: Clinical prospects
DJ Rader, UJ Tietge
Current Atherosclerosis Reports 1999
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, J Delattre
Clinical Chemistry and Laboratory Medicine 1999
A HMG-CoA Reductase Inhibitor Improved Regression of Atherosclerosis in the Rabbit Aorta without Affecting Serum Lipid Levels: Possible Relevance of Up-Regulation of Endothelial NO Synthase mRNA
H Kano, T Hayashi, D Sumi, T Esaki, Y Asai, NK Thakur, M Jayachandran, A Iguchi
Biochemical and Biophysical Research Communications 1999
Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis
GA Francis, RJ Perry
Clinica Chimica Acta 1999
Low-density lipoprotein-independent effects of statins
EM Rubin, BY Ishida, SM Clift, RM Krauss
Current Opinion in Lipidology 1999
Apolipoprotein A-I of Hyperlipidemia Atherosclerosis Prone (LAP) Quail: cDNA Sequence and Tissue Expression
H IWASAKI, H OKU, T TODA, T NASU, K ODA, T MIYAGI, I CHINEN
Bioscience, Biotechnology, and Biochemistry 1999
Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice
MH Moghadasian, DV Godin, BM McManus, JJ Frohlich
Life Sciences 1999
Pathophysiology and management of low high-density lipoprotein cholesterol
DJ Rader
The American Journal of Cardiology 1999
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans
M Eriksson, LA Carlson, TA Miettinen, B Angelin
Circulation 1999
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
RK Tangirala, K Tsukamoto, SH Chun, D Usher, E Puré, DJ Rader
Circulation 1999
Inhibition of arterial thrombus formation by ApoA1 Milano
D Li, S Weng, B Yang, DS Zander, T Saldeen, WW Nichols, S Khan, JL Mehta
Arteriosclerosis, thrombosis, and vascular biology 1999
Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
B Föger, M Chase, MJ Amar, BL Vaisman, RD Shamburek, B Paigen, J Fruchart-Najib, JA Paiz, CA Koch, RF Hoyt, HB Brewer, S Santamarina-Fojo
The Journal of biological chemistry 1999
Lipoprotein A-I Structure
V Koppaka, PH Axelsen
Trends in Cardiovascular Medicine 1999
Hamsters and Guinea Pigs Differ in Their Plasma Lipoprotein Cholesterol Distribution when Fed Diets Varying in Animal Protein, Soluble Fiber, or Cholesterol Content
ML Fernandez, TA Wilson, K Conde, M Vergara-Jimenez, RJ Nicolosi
The Journal of nutrition 1999
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
P Benoit, F Emmanuel, JM Caillaud, L Bassinet, G Castro, P Gallix, JC Fruchart, D Branellec, P Denèfle, N Duverger
Circulation 1999
Reverse Cholesterol Transport and Atherosclerosis Regression
DK Spady
Circulation 1999
High-Density Lipoproteins Differentially Modulate Cytokine-Induced Expression of E-Selectin and Cyclooxygenase-2
GW Cockerill, J Saklatvala, SH Ridley, H Yarwood, NE Miller, B Oral, S Nithyanathan, G Taylor, DO Haskard
Arteriosclerosis, thrombosis, and vascular biology 1999
Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions
K Hirano, S Yamashita, Y Nakagawa, T Ohya, F Matsuura, K Tsukamoto, Y Okamoto, A Matsuyama, K Matsumoto, J Miyagawa, Y Matsuzawa
Circulation research 1999
Contemporary Concepts in Cardiology
R Gorlin, G Dangas, PK Toutouzas, MM Konstadoulakis
1999
Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1
G Lambert, MB Chase, K Dugi, A Bensadoun, HB Brewer, S Santamarina-Fojo
Journal of lipid research 1999
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg
Endocrinology & Metabolism Clinics of North America 1998
Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles
WV Rodrigueza, SK Klimuk, PH Pritchard, MJ Hope
Biochimica et Biophysica Acta (BBA) - Biomembranes 1998
Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells
A Cucina, S Pagliei, V Borrelli, V Corvino, F Stipa, A Cavallaro, AV Sterpetti
European Journal of Vascular and Endovascular Surgery 1998
Antiatherosclerotic potency of high density lipoprotein of different origins: a review and some new findings
A Beitz, J Beitz
Prostaglandins, Leukotrienes and Essential Fatty Acids 1998
A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging
T Hara, M Kusunoki, K Tsutsumi, K Okada, S Sakamoto, M Ohnaka, T Nakamura, T Miyata, K Nakayama, A Fukatsu, K Kato, S Kakumu, Y Nakaya
European Journal of Pharmacology 1998
Evaluation of Lipoproteins/Apolipoproteins as Therapeutic Agents for the Treatment of Vascular and Nonvascular Disease
CR Sirtori
The American Journal of Cardiology 1998
Atherothrombosis: mechanisms and clinical therapeutic approaches
V Fuster, JJ Badimon, JH Chesebro
Vascular medicine (London, England) 1998
Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
PK Shah, J Nilsson, S Kaul, MC Fishbein, H Ageland, A Hamsten, J Johansson, F Karpe, B Cercek
Circulation 1998
Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells
FY Jin, VS Kamanna, ML Kashyap
Arteriosclerosis, thrombosis, and vascular biology 1998
Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta
Y Ishikawa, Y Akasaka, T Ishii, K Komiyama, S Masuda, N Asuwa, NH Choi-Miura, M Tomita
Arteriosclerosis, thrombosis, and vascular biology 1998
The cardiac toxicity of anabolic steroids
ML Sullivan, CM Martinez, P Gennis, EJ Gallagher
Progress in Cardiovascular Diseases 1998
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
E Voyiaziakis, IJ Goldberg, AS Plump, EM Rubin, JL Breslow, LS Huang
Journal of lipid research 1998
Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species
PG Yancey, WG Jerome
Journal of lipid research 1998
INHIBITION OF ENDOTHELIAL CELL ADHESION MOLECULE EXPRESSION BY HIGH DENSITY LIPOPROTEINS
PJ Barter
Clinical and Experimental Pharmacology and Physiology 1997
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase
AM Bérard, B Föger, A Remaley, R Shamburek, BL Vaisman, G Talley, B Paigen, RF Hoyt, S Marcovina, HB Brewer, S Santamarina-Fojo
Nature Medicine 1997
Gene therapy for atherosclerosis
DJ Rader
International Journal of Clinical & Laboratory Research 1997
Gene Activation, Apolipoprotein A-I/High Density Lipoprotein, Atherosclerosis Prevention and Longevity
PV Luoma
Pharmacology & Toxicology 1997
Human Lesion Studies
V Fuster
Annals of the New York Academy of Sciences 1997
Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins
L Calabresi, G Franceschini, CR Sirtori, AD Palma, M Saresella, P Ferrante, D Taramelli
Biochemical and Biophysical Research Communications 1997
Nikolaj Nikolajewitsch Anitschkow (1885–1964) established the cholesterol-fed rabbit as a model for atherosclerosis research
G Finking, H Hanke
Atherosclerosis 1997
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery
M Syvänne, MR Taskinen, MS Nieminen, V Manninen, YA Kesäniemi, A Pasternack, JW Nawrocki, H Haber, MH Frick
Controlled Clinical Trials 1997
Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease
AP Mansur, B Caramelli, CB Vianna, D Chamone, JA Ramires
International Journal of Cardiology 1997
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
M Viñals, J Martínez-González, JJ Badimon, L Badimon
Arteriosclerosis, thrombosis, and vascular biology 1997
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells: Implication for Reverse Cholesterol Transport
FY Jin, VS Kamanna, ML Kashyap
Arteriosclerosis, thrombosis, and vascular biology 1997
Molecular Basis of Fish-Eye Disease in a Patient From Spain: Characterization of a Novel Mutation in the LCAT Gene and Lipid Analysis of the Cornea
F Blanco-Vaca, SJ Qu, C Fiol, HZ Fan, Q Pao, A Marzal-Casacuberta, JJ Albers, I Hurtado, V Gracia, X Pintó, T Martí, HJ Pownall
Arteriosclerosis, thrombosis, and vascular biology 1997
Lysophosphatidylcholine Promotes Cholesterol Efflux From Mouse Macrophage Foam Cells
S Hara, T Shike, N Takasu, T Mizui
Arteriosclerosis, thrombosis, and vascular biology 1997
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker
1997
Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin
LK Hennessy, ST Kunitake, M Jarvis, RL Hamilton, G Endeman, A Protter, JP Kane
Journal of lipid research 1997
Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
AJ Mendez
Journal of lipid research 1997
Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus
K Tsukamoto, KG Hiester, P Smith, DC Usher, JM Glick, DJ Rader
Journal of lipid research 1997
Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors
Karas
Journal of Thrombosis and Thrombolysis 1997
Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid
L Lindstedt, M Lee, GR Castro, JC Fruchart, PT Kovanen
Journal of Clinical Investigation 1996
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
S Zhong, DS Sharp, JS Grove, C Bruce, K Yano, JD Curb, AR Tall
Journal of Clinical Investigation 1996
High density lipoproteins and coronary heart disease
PJ Barter, KA Rye
Atherosclerosis 1996
Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns
BE Cham, KM Kostner, AK Dwivedy, TM Shafey, NX Fang, MG Mahon, CI Iannuzzi, DM Colguhoun, JL Smith
Journal of Clinical Apheresis 1996
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein
M Syvänne, G Castro, C Dengremont, CD Geitere, M Jauhiainen, C Ehnholm, S Michelagnoli, G Franceschini, J Kahri, MR Taskinen
Atherosclerosis 1996
Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis
JM Hoeg, S Santamarina-Fojo, AM Bérard, JF Cornhill, EE Herderick, SH Feldman, CC Haudenschild, BL Vaisman, RF Hoyt, SJ Demosky, RD Kauffman, CM Hazel, SM Marcovina, HB Brewer
Proceedings of the National Academy of Sciences 1996
PATHOPHYSIOLOGY OF PLAQUE RUPTURE AND THE CONCEPT OF PLAQUE STABILIZATION
PK Shah
Cardiology Clinics 1996
Molecular Disorders of Cholesteryl Ester Transfer Protein
S Yamashita, T Arai, K Hirano, N Sakai, M Ishigami, N Nakajima, Y Matsuzawa
Journal of Atherosclerosis and Thrombosis 1996
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
MN Nanjee, JR Crouse, JM King, R Hovorka, SE Rees, ER Carson, JJ Morgenthaler, P Lerch, NE Miller
Arteriosclerosis, thrombosis, and vascular biology 1996
Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver
N Duverger, C Viglietta, L Berthou, F Emmanuel, A Tailleux, L Parmentier-Nihoul, B Laine, C Fievet, G Castro, JC Fruchart, LM Houbebine, P Denèfle
Arteriosclerosis, thrombosis, and vascular biology 1996
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson
1996
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis
AV Bruschke, JH Reiber, KI Lie, HJ Wellens
1996
Unstable angina: New insights into pathophysiologic characteristics, prognosis, and management strategies
PA Ribeiro, PM Shah
Current Problems in Cardiology 1996
Molecular Reviews in Cardiovascular Medicine
K Lindpaintner, D Ganten
1996
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller
1996
High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm
K Miwa, M Fujita, Y Miyagi, H Inoue, S Sasayama
Clinical Cardiology 1995
Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits
H Mezdour, T Yamamura, S Nomura, A Yamamoto
Atherosclerosis 1995
New targets for lipid lowering and atherosclerosis prevention
CR Sirtori
Pharmacology & Therapeutics 1995
In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholine
J Westman, C Roobol, LA Carlson, E Wülfert
Scandinavian Journal of Clinical & Laboratory Investigation 1995
Gene therapy for the vulnerable plaque
LJ Feldman, JM Isner
Journal of the American College of Cardiology 1995
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
GN Levine, JF Keaney, JA Vita
New England Journal of Medicine 1995
Atherogenic dyslipidemia: Lipoprotein abnormalities and implications for therapy
SM Grundy
The American Journal of Cardiology 1995
Elucidation off the role of plaque instability and rupture in acute coronary events
V Fuster
The American Journal of Cardiology 1995
Signal sorting by G-protein-linked receptors
G Milligan
Advances in pharmacology (San Diego, Calif.) 1995
Multi-functional Aspects of High Density Lipoprotein as an Anti-atherogenic Lipoprotein in vivo : Evidence from in vitro Experiments Using Macrophages
A Miyazaki, M Sakai, H Hakamata, S Horiuchi
Journal of Atherosclerosis and Thrombosis 1995
The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study*
JA Leuven, MJ van der Mooren, R Buytenhek
Fertility and Sterility 1995
Antioxidants and Cardiovascular Disease
KR Bruckdorfer
1995
Arterial Thrombosis for the Clinician
RC Becker
Cardiology Clinics 1995
Effects of 1 Year of Growth Hormone Therapy on Serum Lipoprotein Levels in Growth Hormone–Deficient Adults: Influence of Gender and Apo(a) and ApoE Phenotypes
G Johannsson, J Oscarsson, T Rosén, O Wiklund, G Olsson, L Wilhelmsen, BA Bengtsson
Arteriosclerosis, thrombosis, and vascular biology 1995
Apolipoprotein A-I Deficiency: Biochemical and Metabolic Characteristics
DS Ng, C Vezina, TS Wolever, A Kuksis, RA Hegele, PW Connelly
Arteriosclerosis, thrombosis, and vascular biology 1995
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti
1995
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
GW Cockerill, KA Rye, JR Gamble, MA Vadas, PJ Barter
Arteriosclerosis, thrombosis, and vascular biology 1995
Apolipoprotein B and E Basic Amino Acid Clusters Influence Low-Density Lipoprotein Association with Lipoprotein Lipase Anchored to the Subendothelial Matrix
U Saxena, BJ Auerbach, E Ferguson, J Wölle, YL Marcel, KH Weisgraber, RA Hegele, CL Bisgaier
Arteriosclerosis, thrombosis, and vascular biology 1995
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa
Arteriosclerosis, thrombosis, and vascular biology 1995
Coronary Plaque Disruption
E Falk, PK Shah, V Fuster
Circulation 1995
Transcription factors as drug targets: opportunities for therapeutic selectivity
T R Butt, S K Karathanasis
Gene expression 1995
Sex steroids and lipoprotein metabolism
JA Leuven
Pharmacology & Therapeutics 1994
Regression of Atherosclerosis
W Krupski
Annals of Vascular Surgery 1994
Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation
T Vogel, NH Guo, R Guy, N Drezlich, HC Krutzsch, DA Blake, A Panet, DD Roberts
Journal of Cellular Biochemistry 1994
Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta
M Ferrer, A Encabo, J Marín, G Balfagón
European Journal of Pharmacology 1994
Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
AS Plump, CJ Scott, JL Breslow
Proceedings of the National Academy of Sciences 1994
Is the antiatherosclerotic potency of HDL modulated by the origin of HDL?
A Beitz, J Beitz, HJ Mest
Prostaglandins, Leukotrienes and Essential Fatty Acids 1994
Effects of Simvastatin and Pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits
PA Jorge, MR Ozaki, K Metze
Experimental and Toxicologic Pathology 1994
Drug control of reverse cholesterol transport
G Franceschini, JP werba, L Calabresi
Pharmacology & Therapeutics 1994
Dyslipidemias and the secondary prevention of coronary heart disease
RS Rosenson, WA Frauenheim, CC Tangney
Disease-a-Month 1994
The metabolism of high-density lipoproteins
AG Lacko
Trends in Cardiovascular Medicine 1994
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
MN Pieters, D Schouten, TJ Berkel
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1994
Structural relation between HDL-binding proteins in porcine liver
RP de Crom, R van Haperen, P Visser, R Willemsen, AW van der Kamp
Arteriosclerosis Thrombosis and Vascular Biology 1994
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits
S Ameli, A Hultgardh-Nilsson, B Cercek, PK Shah, JS Forrester, H Ageland, J Nilsson
Circulation 1994
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology
V Fuster
Circulation 1994
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis
H Drexel, FW Amann, J Beran, K Rentsch, R Candinas, J Muntwyler, A Luethy, T Gasser, F Follath
Circulation 1994
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol
WP Kopfler, M Willard, T Betz, JE Willard, RD Gerard, RS Meidell
Circulation 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity
RM Epand, A Stafford, B Leon, PE Lock, EM Tytler, JP Segrest, GM Anantharamaiah
Arteriosclerosis Thrombosis and Vascular Biology 1994
Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice
AC Liu, RM Lawn, JG Verstuyft, EM Rubin
Journal of lipid research 1994
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis
K Tsutsumi, Y Inoue, A Shima, K Iwasaki, M Kawamura, T Murase
Journal of Clinical Investigation 1993
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene
KJ Lackner, H Dieplinger, G Nowicka, G Schmitz
Journal of Clinical Investigation 1993
Animal models of human lipid metabolism
KE Suckling, B Jackson
Progress in Lipid Research 1993
Reverse cholesterol transport: relationship between free cholesterol uptake and HDL3 in normolipidaemic and hyperlipidaemic subjects
MC Cabezas, GP van Heusden, TW de Bruin, JR van Beckhoven, LA Kock, KW Wtrtz, DW Erkelens
European Journal of Clinical Investigation 1993
Toward the quiescent coronary plaque
AI MacIsaac, JA Thomas, EJ Topol
Journal of the American College of Cardiology 1993
Adenine for guanine substitution - pairs 5‘ to the apolipoprotein (APO) A4 gene: relation with hgh density lipoprotein cholesterol and APO A-I concentrations
F Civeira, M Pocovi, A Cenarro, C Garces, JM Ordovas
Clinical Genetics 1993
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
DJ Rader, JR Schaefer, P Lohse, K Ikewaki, F Thomas, WA Harris, LA Zech, CA Dujovne, HB Brewer
Metabolism 1993
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells
Y Ko, R Häring, H Stiebler, AJ Wieczorek, H Vetter, A Sachinidis
Atherosclerosis 1993
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
HB Rubins, SJ Robins, MK Iwane, WE Boden, MB Elam, CL Fye, DJ Gordon, EJ Schaefer, G Schectman, JT Wittes
The American Journal of Cardiology 1993
The role of subfractions of high density lipoprotein in the in vivo transport of cholesterol from cholesterol-loaded hepatic and peripheral endothelial cells in the new zealand white rabbit
YD Fragoso, ER Skinner
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry 1993
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice
C Glass, RC Pittman, DB Weinstein, D Steinberg
Arteriosclerosis Thrombosis and Vascular Biology 1993
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins
D Crook, IF Godsland, M Worthington, CV Felton, AJ Proudler, JC Stevenson
American Journal of Obstetrics and Gynecology 1993
Growth Factors and the Cardiovascular System
P Cummins
1993
Human Apolipoprotein Mutants III
CR Sirtori, G Franceschini, BH Brewer
1993
Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix
U Saxena, E Ferguson, CL Bisgaier
The Journal of biological chemistry 1993
Concentration and distribution of apolipoproteins A-I and E in normolipidemic, WHHL and diet-induced hyperlipidemic rabbit sera
H Mezdour, S Nomura, T Yamamura, A Yamamoto
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1992
Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis protection
RN Amarasuriya, AK Gupta, M Civen, YC Horng, T Maeda, ML Kashyap
Metabolism 1992
Does a HDL injection reduce the development of serum hyperlipidemia and progression of fatty streaks in cholesterol fed rabbits?
J Beitz, A Beitz, IV Antonov, AY Misharin, HJ Mest
Prostaglandins, Leukotrienes and Essential Fatty Acids 1992
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
FH Epstein, V Fuster, L Badimon, JJ Badimon, JH Chesebro
New England Journal of Medicine 1992
High density lipoprotein mediates selective reduction in cholesteryl esters from macrophage foam cells
A Miyazaki, AT Rahim, T Ohta, Y Morino, S Horiuchi
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1992
Norgestimate: A clinical overview of a new progestin
J Bringer
American Journal of Obstetrics and Gynecology 1992
Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol
M Miller, A Seidler, PO Kwiterovich, TA Pearson
Circulation 1992
Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty
PK Shah, J Amin
Circulation 1992
High density lipoprotein deficiency syndrome in chickens is not associated with an increased susceptibility to atherosclerosis
F Poernama, R Subramanian, ME Cook, AD Attie
Arteriosclerosis Thrombosis and Vascular Biology 1992
Reverse cholesterol transport: Physiology and pharmacology
G Franceschini, P Maderna, CR Sirtori
Atherosclerosis 1991
More on Chewing the Fat
FM Sacks, WW Willett
New England Journal of Medicine 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
Cholesterol transport between cells and high-density lipoproteins
WJ Johnson, FH Mahlberg, GH Rothblat, MC Phillips
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1991
Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement
V Dzau, E Braunwald
American Heart Journal 1991
Accelerated coronary atherosclerosis in cardiac transplantation
DO Taylor, HM Ibrahim, DR Tolman, ML Hess
Transplantation Reviews 1991
Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice
T Hayek, T Chajek-Shaul, A Walsh, N Azrolan, JL Breslow
Arteriosclerosis Thrombosis and Vascular Biology 1991
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
JH Ip, V Fuster, L Badimon, J Badimon, MB Taubman, JH Chesebro
Journal of the American College of Cardiology 1990
Animal models of atherosclerosis
ML Armstrong, DD Heistad
Atherosclerosis 1990
The Biology of the Laboratory Rabbit
HA Hartman
The Biology of the Laboratory Rabbit 1974

← Previous 1 2 3 … 24 25 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 79 patents
Referenced in 1 clinical guideline sources
145 readers on Mendeley
See more details